is retatrutide on the market UK 2026: Phase 3 Results The Thriving Black Market for

Specific escalation schedules varied by trial protocol, and the full range of doses studied is described in the published Phase 2 trial data

This is the same active ingredient in the injectable version of Wegovy and became available for private prescription in June 2026

Food noise returns

Fasting insulin, C-peptide, and HOMA2-IR decreased by 50% or more from baseline

Contribution of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1C) // Diabetes Care

GLP3, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: A randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA